Indications and Usage for Nascobal NASCOBAL is indicated for: Vitamin B12 maintenance therapy in adult patients with pernicious anemia who are in remission following intramuscular vitamin B12 therapy and who have no nervous system involvement Treatment of adult patients with dietary, drug-induced, or malabsorption-related vitamin B12 deficiency not due to pernicious anemia Prevention of vitamin B12 deficiency in adult patients with vitamin B12 requirements in excess of normal Limitations of Use NASCOBAL should not be used for the vitamin B12 absorption test (Schilling test)
vegans, elderly) are suggestive of subclinical deficiency, and with borderline or low normal serum B12 when confirming a deficiency through numerous tests is not possible
Enhanced topical: microneedling + GHK-Cu Rolling the scalp or face with a 0.5 mm derma roller or undergoing in-clinic microneedling before GHK-Cu application creates micro-channels that dramatically improve bioavailability
A provider can evaluate whether medical weight loss, peptide therapy, nutrition support, hormone testing, or lifestyle changes are more appropriate
Some users notice subtle metabolic changes like increased energy or reduced appetite within the first 1-2 weeks
Product-specific reports Primary Current batch report 0.70 mg/ml Cyanocobalamin Batch PP2602-004 Tested size 10mg/10mL Janoshik #194153 Laboratory Research Use Only